$ATMC
ALPHATIME ACQUISITION CORP Stock $atmc

$atmc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224014684 Filed on April 15, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$290.5K	$723.1K	$1.189M
YoY Change	107.05%	92601.28%	151568.49%
Operating Profit
YoY Change
Interest Expense	$675.8K	$951.4K	$3.130M
YoY Change	-19.54%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$385.4K	$228.3K	$1.941M
YoY Change	-44.95%	-29367.95%	-248961.54%
Income Tax
% Of Pretax Income
Net Earnings	$385.4K	$228.3K	$1.941M
YoY Change	-45.07%	-29367.95%	-247691.58%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.06	$0.03	$0.22
COMMON SHARES
Basic Shares Outstanding	6.873M shares	9.034M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.470K	$15.05K	$15.05K
YoY Change	-98.87%
Cash & Equivalents	$1.473K	$15.05K
Short-Term Investments
Other Short-Term Assets	$62.82K	$43.05K	$43.05K
YoY Change	-37.18%	-92.74%	-92.74%
Inventory
Prepaid Expenses	$62.82K	$43.05K
Receivables
Other Receivables
Total Short-Term Assets	$64.30K	$58.11K	$58.11K
YoY Change	-71.72%	-90.19%	-90.19%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$52.55M	$74.06M	$74.06M
YoY Change	-26.83%
Other Assets
YoY Change
Total Long-Term Assets	$52.55M	$74.06M	$74.06M
YoY Change	-26.82%
TOTAL ASSETS
Total Short-Term Assets	$64.30K	$58.11K	$58.11K
Total Long-Term Assets	$52.55M	$74.06M	$74.06M
Total Assets	$52.62M	$74.12M	$74.12M
YoY Change	-26.96%	12408.28%	12408.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$1.018M	$649.6K	$649.6K
YoY Change	475.66%	230.07%	230.06%
Deferred Revenue
YoY Change
Short-Term Debt	$1.043M	$690.0K	$690.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.510M	$1.539M	$1.539M
YoY Change	1319.19%	166.54%	166.54%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.415M	$2.415M	$2.415M
YoY Change	-0.21%
Total Long-Term Liabilities	$2.415M	$2.415M	$2.415M
YoY Change	-0.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.510M	$1.539M	$1.539M
Total Long-Term Liabilities	$2.415M	$2.415M	$2.415M
Total Liabilities	$4.925M	$3.954M	$3.954M
YoY Change	90.03%	584.81%	584.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.861M	-$3.896M
YoY Change	105.58%	39647.14%
Common Stock	$214.00	$214.00
YoY Change	0.0%	23.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.861M	-$3.896M	$70.17M
YoY Change
Total Liabilities & Shareholders Equity	$52.62M	$74.12M	$74.12M
YoY Change	-26.96%	12408.28%	12408.28%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$385.4K	$228.3K	$1.941M
YoY Change	-45.07%	-29367.95%	-247691.58%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$10.45K	-$46.06K	-$376.1K
YoY Change	-65.17%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$165.0K	-$692.0K	-$70.93M
YoY Change
Cash From Investing Activities	-$165.0K	-$692.0K	-$70.93M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$69.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	167.5K	693.1K	$71.32M
YoY Change	-658.33%
NET CHANGE
Cash From Operating Activities	-10.45K	-46.06K	-$376.1K
Cash From Investing Activities	-165.0K	-692.0K	-$70.93M
Cash From Financing Activities	167.5K	693.1K	$71.32M
Net Change In Cash	-7.950K	-44.95K	$15.05K
YoY Change	-86.75%
FREE CASH FLOW
Cash From Operating Activities	-$10.45K	-$46.06K	-$376.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q4	us-gaap	Cash Cash		usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent		usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating		usd
CY2023	ATMC	Adjustments To Additional Paid In Capital Transfer Of Negative Apic To Accumulated Deficit AdjustmentsToAdditionalPaidInCapitalTransferOfNegativeApicToAccumulatedDeficit		usd
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating		usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments		usd
CY2022	ATMC	Payment For Purchase Of Investments In Trust Account PaymentForPurchaseOfInvestmentsInTrustAccount		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	ATMC	Proceeds From Issuance Of Promissory Notes ProceedsFromIssuanceOfPromissoryNotes		usd
CY2022	ATMC	Payment Of Underwriting Discount PaymentOfUnderwritingDiscount		usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect		usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2022	ATMC	Deferred Offering Costs Charged To Apic DeferredOfferingCostsChargedToApic		usd
CY2022	ATMC	Deferred Offering Cost Related To Fair Value Of Unit Purchase Option Net Of Proceeds DeferredOfferingCostRelatedToFairValueOfUnitPurchaseOptionNetOfProceeds		usd
CY2022	ATMC	Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption		usd
CY2022	ATMC	Reclassification Of Ordinary Shares Subject To Redemption ReclassificationOfOrdinarySharesSubjectToRedemption		usd
CY2022	ATMC	Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption		usd
CY2022	ATMC	Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Income Earned On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionIncomeEarnedOnTrustAccount		usd
CY2022	ATMC	Deferred Underwriting Commission Charged To Apic DeferredUnderwritingCommissionChargedToApic		usd
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating		usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	75869496	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6873426	shares
CY2023	dei	Auditor Firm AuditorFirmId	1195
CY2023	dei	Auditor Name AuditorName	UHY LLP
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q4	us-gaap	Cash Cash	15054	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	43052	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	8052	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	584518	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	58106	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	592570	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	74062199	usd
CY2023Q4	us-gaap	Assets Assets	74120305	usd
CY2022Q4	us-gaap	Assets Assets	592570	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	649589	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	196806	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1538907	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	577372	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2415000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3953907	usd
CY2022Q4	us-gaap	Liabilities Liabilities	577372	usd
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	6900000	shares
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.73
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	74062199	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2134200	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2134200	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1725000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1725000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	214	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	173	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	214	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	173	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24827	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3896015	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9802	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3895801	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15198	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	74120305	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	592570	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1189081	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	784	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1189081	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	784	usd
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	3130199	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15982	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-784	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15198	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15198	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60000000	usd
CY2023	ATMC	Stock Issued During Period Value Overallotment Of Ordinary Shares StockIssuedDuringPeriodValueOverallotmentOfOrdinaryShares	9000000	usd
CY2023	ATMC	Stock Issued During Period Value Issuance Of Ordinary Shares For Private Units StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesForPrivateUnits	3705000	usd
CY2023	ATMC	Stock Issued During Period Value Overallotment Of Private Units StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits	387000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	10781	usd
CY2023	ATMC	Adjustment To Additional Paid In Capital Underwriting Discount AdjustmentToAdditionalPaidInCapitalUnderwritingDiscount	-1612500	usd
CY2023	ATMC	Stock Issued During Period Value Deferred Underwriting Commission StockIssuedDuringPeriodValueDeferredUnderwritingCommission	-2415000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-865199	usd
CY2023	ATMC	Stock Issued During Period Value Initial Measurement Of Ordinary Shares Subject To Redemption Against Additional Paidin Capital StockIssuedDuringPeriodValueInitialMeasurementOfOrdinarySharesSubjectToRedemptionAgainstAdditionalPaidinCapital	-67275000	usd
CY2023	ATMC	Adjustments To Additional Paid In Capital Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	4770382	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	-7737382	usd
CY2023	ATMC	Stock Issued During Period Value Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Income Earned On Trust Account StockIssuedDuringPeriodValueSubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionIncomeEarnedOnTrustAccount	-3820199	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1941118	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1941118	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3895801	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1941118	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-784	usd
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	3130199	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	35000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	8466	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	674635	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-31552	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	173389	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	40802	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-376057	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	70242000	usd
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	71915996	usd
CY2023	ATMC	Payment For Purchase Of Investments In Trust Account PaymentForPurchaseOfInvestmentsInTrustAccount	72605996	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-70932000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	69000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	4092000	usd
CY2023	ATMC	Proceeds From Issuance Of Promissory Notes ProceedsFromIssuanceOfPromissoryNotes	690000	usd
CY2023	ATMC	Payment Of Underwriting Discount PaymentOfUnderwritingDiscount	1612500	usd
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	100	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	368066	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	478423	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	71323111	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15054	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15054	usd
CY2023	ATMC	Deferred Offering Costs Included In Accrued Expenses DeferredOfferingCostsIncludedInAccruedExpenses	3640	usd
CY2022	ATMC	Deferred Offering Costs Included In Accrued Expenses DeferredOfferingCostsIncludedInAccruedExpenses	117843	usd
CY2023	ATMC	Deferred Offering Costs Paid By Related Party DeferredOfferingCostsPaidByRelatedParty	13429	usd
CY2022	ATMC	Deferred Offering Costs Paid By Related Party DeferredOfferingCostsPaidByRelatedParty	47834	usd
CY2023	ATMC	Deferred Offering Costs Adjusted From Prepaid Expenses DeferredOfferingCostsAdjustedFromPrepaidExpenses	60	usd
CY2022	ATMC	Deferred Offering Costs Adjusted From Prepaid Expenses DeferredOfferingCostsAdjustedFromPrepaidExpenses	414	usd
CY2023	ATMC	Deferred Offering Costs Charged To Apic DeferredOfferingCostsChargedToApic	865199	usd
CY2023	ATMC	Deferred Offering Cost Related To Fair Value Of Unit Purchase Option Net Of Proceeds DeferredOfferingCostRelatedToFairValueOfUnitPurchaseOptionNetOfProceeds	10681	usd
CY2023	ATMC	Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	4770382	usd
CY2023	ATMC	Reclassification Of Ordinary Shares Subject To Redemption ReclassificationOfOrdinarySharesSubjectToRedemption	67274310	usd
CY2023	ATMC	Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption	8427382	usd
CY2023	ATMC	Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Income Earned On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionIncomeEarnedOnTrustAccount	3130199	usd
CY2023	ATMC	Deferred Underwriting Commission Charged To Apic DeferredUnderwritingCommissionChargedToApic	2415000	usd
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2021-09-15
CY2023Q1	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	70242000	usd
CY2023Q4	us-gaap	Cash Cash	15054	usd
CY2023Q4	ATMC	Working Capital WorkingCapital	-1480801	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	690000	usd
CY2023Q4	us-gaap	Payments For Deposits PaymentsForDeposits	55000	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2160774	shares
CY2023Q4	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	23302146	usd
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.78
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	51108602	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6873426	shares
CY2023Q1	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	70242000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zVyBR2bYXGse" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zjaWMuoiHym4">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statement in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zBcB9ndZQuK7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zzJQ5xd3ET7h">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zejXxhfsecC2" title="Cash, FDIC insured amount">250,000</span>. On December 31, 2023, the Company did not experience losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1941118	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-784	usd
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	3130199	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	8427382	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9616463	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-784	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2023Q1	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	70242000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.18
CY2023Q1	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	The Founder Shares and Private Units (and underlying securities) will not, subject to certain exceptions, be transferred, assigned, sold or released from escrow in the case of (i) 50% of the Founder Shares and Private Units (and underlying securities) until the earlier to occur of: (A) six months after the date of the consummation of our initial business combination, or (B) the date on which the closing price of our ordinary shares equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after our initial business combination and (ii) the remaining 50% of the Founder Shares and Private Units (and underlying securities) until six months after the date of the consummation of our initial business combination, or earlier, in either case, if, subsequent to our initial business combination, we consummate a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of our shareholders having the right to exchange their shares for cash, securities or other property.
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	120000	usd
CY2023Q1	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	1500000	usd
CY2023Q1	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	112500	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	The option and the 58,000 Units, as well as the 58,000 ordinary shares, the warrants to purchase 58,000 ordinary shares that may be issued upon exercise of the option and the rights to purchase 5,800 ordinary shares upon the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the commencement of sales in our IPO pursuant to Rule 5110(e)(1) of FINRA’s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the securities, except as permitted under FINRA Rule 5110(e)(2). The Company determined fair value of the Unit Purchase Option issued to the underwriters and recorded an amount to additional paid-in capital, net of purchased cost, in the balance sheets on the day of the IPO which is the grant date.
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	58000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	58000	shares
CY2022Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5800	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of ordinary shares are entitled to one vote for each share. Further, the shareholders also approved the amendment and restatement of the memorandum and articles of association filed with the Cayman Registrar.
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	115500	shares
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.00
CY2023Q1	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	231000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2134200	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2134200	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	6900000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1725000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1725000	shares
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	74062199	usd
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	74062199	usd

Files In Submission

Name	View Source	Status
0001493152-24-014684-index-headers.html	Edgar Link	pending
0001493152-24-014684-index.html	Edgar Link	pending
0001493152-24-014684.txt	Edgar Link	pending
0001493152-24-014684-xbrl.zip	Edgar Link	pending
atmc-20231231.xsd	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
atmc-20231231_cal.xml	Edgar Link	unprocessable
atmc-20231231_def.xml	Edgar Link	unprocessable
atmc-20231231_lab.xml	Edgar Link	unprocessable
atmc-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ATMC
ALPHATIME ACQUISITION CORP Stock $atmc

2024 Q2 Form 10-K Financial Statement

#000149315224014684 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATMC ALPHATIME ACQUISITION CORP Stock $atmc

2024 Q2 Form 10-K Financial Statement

#000149315224014684 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATMC
ALPHATIME ACQUISITION CORP Stock $atmc